Ftse Mib
34.183,85
-0,56%
DAX
18.504,42
-0,51%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
62.811,48
-3,15%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ AbCellera Biologics Inc (ABCL) AbCellera Biologics Inc (ABCL) Notizie

ABCL

AbCellera Biologics (ABCL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABCL
DataOraFonteTitoloSimboloCompagnia
16/02/202122:38Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ABCLAbCellera Biologics Inc
16/02/202112:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ABCLAbCellera Biologics Inc
11/02/202122:05Business WireAbCellera Appoints Ester Falconer, Ph.D., as Chief Technology OfficerNASDAQ:ABCLAbCellera Biologics Inc
10/02/202102:26Business WireAbCellera-Discovered Antibody, Bamlanivimab, Administered with Etesevimab Receives FDA Emergency Use Authorization for COVID-19NASDAQ:ABCLAbCellera Biologics Inc
03/02/202122:05Business WireAbCellera Announces Date of Fourth Quarter 2020 Financial Results Conference CallNASDAQ:ABCLAbCellera Biologics Inc
27/01/202113:22Business WireAbCellera-Discovered Antibody, Bamlanivimab, to be Developed with VIR-7831 for the Treatment of COVID-19NASDAQ:ABCLAbCellera Biologics Inc
26/01/202113:09Business WireAbCellera-Discovered Antibody, Bamlanivimab, Administered with Etesevimab Reduced Risk of COVID-19 Hospitalizations & Death b...NASDAQ:ABCLAbCellera Biologics Inc
21/01/202114:27Business WireAbCellera-Discovered Antibody Prevented COVID-19 in Nursing Homes and Reduced Risks by up to 80% for ResidentsNASDAQ:ABCLAbCellera Biologics Inc
19/01/202122:41Business WireAbCellera Granted U.S. Patent Covering its Trianni Mouse® TechnologyNASDAQ:ABCLAbCellera Biologics Inc
11/01/202116:18Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:ABCLAbCellera Biologics Inc
05/01/202115:30PR Newswire (Canada)2020 Canadian IPO mixed results - number (77) down, amount ($5.55B) up driven by PE-backed IPOsNASDAQ:ABCLAbCellera Biologics Inc
21/12/202015:00Business WireAbCellera-Discovered Neutralizing Antibody for COVID-19 Enters New Pragmatic Study in New MexicoNASDAQ:ABCLAbCellera Biologics Inc
16/12/202003:03Business WireAbCellera Announces Closing of Initial Public Offering & Exercise in Full of the Underwriters’ Option to Purchase Additiona...NASDAQ:ABCLAbCellera Biologics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABCL

La tua Cronologia

BIT
FBK
Finecobank
BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
RACE
Ferrari NV
BIT
ENI
Eni
BIT
BC
Brunello Cucinelli
BIT
SPM
Saipem
BIT
G
Generali
BIT
LDO
Leonardo
BIT
MONC
Moncler
BIT
STMMI
ST Microelectronics
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
PRY
Prysmian
BIT
BPE
Bper Banca
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network